InvestorsHub Logo

DewDiligence

08/20/11 2:59 PM

#4655 RE: Br757 #4653

My assessment of management’s credentials, experience, and potential was woefully wrong.

LOL—I warned you (on several occasions) that this company was a scam, but you evidently didn’t want to listen.

p.s. Fibrocell’s technology is not nearly as impressive as you seem to believe.

EYEBUYSTOX

08/20/11 11:35 PM

#4657 RE: Br757 #4653

While I understand your frustrations and share in a lot of your thoughts, to cast stones at management at this point is, IMO, premature. When management gives their side of the story I believe their actions will be justified. They are aware of shareholder frustration and know they must be able to answer for their actions. Attempting to analyze this situation without all of the facts is foolish. The technology is not over-valued. To the contrary, because it's one of a kind it's almost impossible to put a value on it's potential. Warren Buffet said it best, "The stock market is simply the transfer of wealth from the impatient to the patient". Those 100k buy blocks scattered over the last 2 months are not a coincidence. They are buying for a reason and I believe that reason will come to light over the next 10 days. Good luck.

laltrader

08/20/11 11:46 PM

#4658 RE: Br757 #4653

Agree. I too am losing patience. What bothers me most is the lack of publicity and public education/promotion of the fact that Fibrocell is one of the first US companies to get approval for autologous cell therapy . Nature reported on this, but it's readership is small.
Http://www.nature.com/nbt/journal/v29/n8/full/nbt0811-674.html?WT.ec_id=NBT-201108xt

Is there something that we as shareholders can do?